High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease

Microbial Pathogenesis

Volumn 47, Issue 6, 2009, Pages 321-328

  Sohn, Hosung ^a   Kim, Hwa Jung ^a,b   Kim, Jin Man ^a,b   Jung Kwon, O ^c   Koh, Won Jung ^c   Shin, Sung Jae ^a,b  

^a Chungnam National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Cytotoxicity; Lung inflammation; Macrophage; Mycobacterium abscessus; Upper lobe fibrocavitary form; Virulence

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL REPRODUCTION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRACELLULAR BACTERIUM; MACROPHAGE; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ADULT; AGED; ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CLARITHROMYCIN; CYTOKINES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LUNG; LUNG DISEASES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SPECIFIC PATHOGEN-FREE ORGANISMS; TOMOGRAPHY, X-RAY COMPUTED; VIRULENCE;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MUS; MYCOBACTERIUM ABSCESSUS;

EID: 71249115120     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.09.010     Document Type: Article

References (26)

1. Brown-Elliott B.A., and Wallace Jr. R.J. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15 (2002) 716-746
2. Griffith D.E., Girard W.M., and Wallace Jr. R.J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147 (1993) 1271-1278
3. Sanguinetti M., Ardito F., Fiscarelli E., La Sorda M., D'Argenio P., Ricciotti G., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 39 (2001) 816-819
4. Wallace Jr. R.J., Swenson J.M., Silcox V.A., Good R.C., Tschen J.A., and Stone M.S. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5 (1983) 657-679
5. Jeon K., Kwon O.J., Lee N.Y., Kim B.J., Kook Y.H., Lee S.H., et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med (2009) 10.1164/rccm.200905-0704OC
6. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007) 367-416
7. The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up patients receiving standardized treatment. Int J Tuberc Lung Dis 67 (2002) 628-634
8. Yamazaki Y., Kubo K., Takamizawa A., Yamamoto H., Honda T., and Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med 160 (1999) 1851-1855
9. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; Approved Standard (2003), NCCLS, Wayne, PA Document No. M24-A
10. Kim H.Y., Kook Y., Yun Y.J., Park C.G., Lee N.Y., Shim T.S., et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae- Mycobacterium abscessus group isolates. J Clin Microbiol 46 (2008) 3384-3390
11. Park J.S., Tamayo M.H., Gonzalez-Juarrero M., Orme I.M., and Ordway D.J. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J Leukoc Biol 79 (2006) 80-86
12. Silver R.F., Li Q., and Ellner J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect Immun 66 (1998) 1190-1199
13. Zhang M., Gong J., Lin Y., and Barnes P.F. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 66 (1998) 794-799
14. Abebe F., and Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?. Clin. Exp Immunol 145 (2006) 389-397
15. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 98 (2001) 5752-5757
16. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84-87
17. Sohn H., Lee K.S., Kim S.Y., Shin D.M., Shin S.J., Jo E.K., et al. Induction of cell death in human macrophages by a highly virulent Korean isolate of Mycobacterium tuberculosis and the virulent strain H37Rv. Scand J Immunol 69 (2009) 43-50
18. Elkington P.T., O'Kane C.M., and Friedland J.S. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142 (2005) 12-20
19. Cosma C.L., Sherman D.R., and Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57 (2003) 641-676
20. Houben E.N., Nguyen L., and Pieters J. Interaction of pathogenic mycobacteria with the host immune system. Curr Opin Microbiol 9 (2006) 76-85
21. Barrow W.W., and Brennan P.J. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J Bacteriol 150 (1982) 381-384
22. Howard S.T., Rhoades E., Recht J., Pang X., Alsup A., Kolter R., et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 152 (2006) 1581-1590
23. Chung M.J., Lee K.S., Koh W.J., Lee J.H., Kim T.S., Kwon O.J., et al. Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: comparison between Mycobacterium avium- intracellulare complex and Mycobacterium abscessus infection. J Korean Med Sci 20 (2005) 777-783
24. Koh W.J., Yu C.M., Suh G.Y., Chung M.P., Kim H., Kwon O.J., et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 10 (2006) 1001-1007
25. Sung N., and Collins M.T. Thermal tolerance of Mycobacterium paratuberculosis. Appl Environ Microbiol 64 (1998) 999-1005
26. Kaushik R.S., Uzonna J.E., Zhang Y., Gordon J.R., and Tabel H. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Cytokine 12 (2000) 1024-1034